Background: Because there are currently many effective therapies available for Sé zary syndrome, close monitoring of disease progression is required in order for a clinician to know when to institute or change an...Background: Because there are currently many effective therapies available for Sé zary syndrome, close monitoring of disease progression is required in order for a clinician to know when to institute or change an intervention. It has been our clinical experience that changes in patients’ CD4+ CD26- T- cell populations of peripheral blood lymphocytes herald changes in their clinical status. Objective: Our purpose was to evaluate whether a change in patients’ CD4+ CD26- population of T cells presages a change in their clinical status. We also sought to investigate the association between a change in Tcell populations that are CD4+ CD7- , CD8+ , CD56+ , and the CD4 + /CD8+ T- cell ratio and a change in the patient’ s clinical status. Methods: We conducted a retrospective chart review analysis of 21 patients with Sé zary syndrome who had flow cytometry, usually including levels of CD4+ CD26- , CD4+ CD7- , CD8+ , CD56+ , and CD4+ /CD8+ ratios measured at two time periods, 12 weeks apart. Results: We report two cases in which changes in patients’ clinical status were preceded by several weeks by a change in their CD4+ CD26- level. We report weak associations between a decreasing CD4+ CD26- T- cell population, a decreasing CD4+ CD7- population, an increasing CD56+ population, and an improving clinical status. We also report stronger associations between both a decreasing CD8+ population and an increasing CD4+ /CD8+ ratio and a worsening clinical status. Limitations: The study was limited by the number of patients and the time period over which the study was conducted. In addition, varying configurations of CD4+ CD26- T- cell populations were observed that may have limited the utility of this measurement. Conclusions: Flow cytometry assays of patients’ blood and, in particular, measurement of the CD4+ CD26- population of lymphocytes over time may be a valuable tool for monitoring patients with Sé zary syndrome. There exist varying configurations of CD26 T lymphocytes that may cause differences in standards for what is considered positive and negative between observers. Further prospective analysis involving larger groups of patients is recommended.展开更多
Background/Aims: Hepatitis C virus (HCV) causes a chronic infection that can lead to fibrosis and carcinoma. Immune responses mediated by cytotoxic T lymphocytes (CTLs) could be involved in viral clearance or persiste...Background/Aims: Hepatitis C virus (HCV) causes a chronic infection that can lead to fibrosis and carcinoma. Immune responses mediated by cytotoxic T lymphocytes (CTLs) could be involved in viral clearance or persistence, and therefore in determining the course of the disease. Methods: Intrahepatic and peripheral blood CD8+ T cells were obtained from 32 HCV-chronically infected patients and analysed by flow-cytometry for surface markers of differentiation, IFNγ and TNFα production, degranulation capacity and perforin content, after CD3 triggering. Results were compared with those obtained from 13 patients with a non-viral liver disease. Results: Intrahepatic CD8+ T cells of HCV-infected patiets, despite their phenotype of pre-terminally and terminally differentiated effectors (CCR7- CD45RA- /+ ), are poorly responsive to T cell receptor (TCR)mediated stimulation compared with those obtained from uninfected subjects. This defect correlates with the severity of fibrosis, is more pronounced in patients with ALT< 1.5× N than with ALT >1.5× N U/ml, and is not evident after mitogen stimulation. Conclusions: The present study describes the accumulation of hypo-responsive CD8+ T cells in the liver of patients with chronic HCV infection. Understanding the mechanisms underlying this impairment may be helpful in the design of innovative strategies for HCV treatment.展开更多
文摘Background: Because there are currently many effective therapies available for Sé zary syndrome, close monitoring of disease progression is required in order for a clinician to know when to institute or change an intervention. It has been our clinical experience that changes in patients’ CD4+ CD26- T- cell populations of peripheral blood lymphocytes herald changes in their clinical status. Objective: Our purpose was to evaluate whether a change in patients’ CD4+ CD26- population of T cells presages a change in their clinical status. We also sought to investigate the association between a change in Tcell populations that are CD4+ CD7- , CD8+ , CD56+ , and the CD4 + /CD8+ T- cell ratio and a change in the patient’ s clinical status. Methods: We conducted a retrospective chart review analysis of 21 patients with Sé zary syndrome who had flow cytometry, usually including levels of CD4+ CD26- , CD4+ CD7- , CD8+ , CD56+ , and CD4+ /CD8+ ratios measured at two time periods, 12 weeks apart. Results: We report two cases in which changes in patients’ clinical status were preceded by several weeks by a change in their CD4+ CD26- level. We report weak associations between a decreasing CD4+ CD26- T- cell population, a decreasing CD4+ CD7- population, an increasing CD56+ population, and an improving clinical status. We also report stronger associations between both a decreasing CD8+ population and an increasing CD4+ /CD8+ ratio and a worsening clinical status. Limitations: The study was limited by the number of patients and the time period over which the study was conducted. In addition, varying configurations of CD4+ CD26- T- cell populations were observed that may have limited the utility of this measurement. Conclusions: Flow cytometry assays of patients’ blood and, in particular, measurement of the CD4+ CD26- population of lymphocytes over time may be a valuable tool for monitoring patients with Sé zary syndrome. There exist varying configurations of CD26 T lymphocytes that may cause differences in standards for what is considered positive and negative between observers. Further prospective analysis involving larger groups of patients is recommended.
文摘Background/Aims: Hepatitis C virus (HCV) causes a chronic infection that can lead to fibrosis and carcinoma. Immune responses mediated by cytotoxic T lymphocytes (CTLs) could be involved in viral clearance or persistence, and therefore in determining the course of the disease. Methods: Intrahepatic and peripheral blood CD8+ T cells were obtained from 32 HCV-chronically infected patients and analysed by flow-cytometry for surface markers of differentiation, IFNγ and TNFα production, degranulation capacity and perforin content, after CD3 triggering. Results were compared with those obtained from 13 patients with a non-viral liver disease. Results: Intrahepatic CD8+ T cells of HCV-infected patiets, despite their phenotype of pre-terminally and terminally differentiated effectors (CCR7- CD45RA- /+ ), are poorly responsive to T cell receptor (TCR)mediated stimulation compared with those obtained from uninfected subjects. This defect correlates with the severity of fibrosis, is more pronounced in patients with ALT< 1.5× N than with ALT >1.5× N U/ml, and is not evident after mitogen stimulation. Conclusions: The present study describes the accumulation of hypo-responsive CD8+ T cells in the liver of patients with chronic HCV infection. Understanding the mechanisms underlying this impairment may be helpful in the design of innovative strategies for HCV treatment.
